While no one is immune from the strains of social distancing and stay-at-home orders, it would be difficult to overstate the impact of isolation on women facing unexpected or difficult pregnancies.
As a recent profile in The New York Times points out, that means big business for enterprising abortion companies—especially the small handful of groups utilizing a Food and Drug Administration loophole to offer their lethal product via video call.
Touted as “telemedicine abortion,” the approach sidesteps regulations by allowing a prescriber to forgo any in-person visits prior to an abortion.
More HERE
